Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole On-Demand vs Daily Maintenance in Chronic Acid Suppression Users
NCT00161096Phase 3Unknown
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of pantoprazole in gastroesophageal reflux disease (GERD) (2 arms). Primary endpoint: Percentage of patients taking 6 or more tablets on-demand per week. Status: unknown.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00161096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161096.